文献速递中毒与环境急症复苏、休克与脓毒症重症综合管理与镇静镇痛

β受体阻滞剂中毒的治疗:一项系统评价

Treatment for beta-blocker poisoning: a systematic review.
PubMed 文献 · Clin Toxicol (Phila) · 2020-04-20
一句话结论β受体阻滞剂中毒的证据多来自低质量研究;儿茶酚胺、血管加压药、高剂量胰岛素正葡萄糖治疗和VA-ECMO与死亡率降低相关,作者认为可采用从静脉输液到儿茶酚胺、高剂量胰岛素及VA-ECMO的阶梯式反应。

所有干预的偏倚风险均高。儿茶酚胺、血管加压药、高剂量胰岛素正葡萄糖治疗和VA-ECMO与死亡率降低相关,但多种治疗常同时给予。作者认为对血流动力学不稳定可采用阶梯式反应:从静脉输液开始,根据血流动力学损害类型(心动过缓、左心室功能障碍、血管扩张)启用单种或联合儿茶酚胺正性肌力药和血管加压药,高剂量胰岛素正葡萄糖治疗可作为辅助正性肌力药,对其它治疗无反应者考虑VA-ECMO。

要点

  • 儿茶酚胺、血管加压药、高剂量胰岛素正葡萄糖治疗和VA-ECMO与β受体阻滞剂中毒死亡率降低相关,但多种治疗常同时给予。
  • 高剂量胰岛素正葡萄糖治疗在10个病例系列中与死亡率获益相关,维持剂量范围为1至10单位/kg/h,低血糖和低钾血症为常见不良反应。
  • 作者认为对血流动力学不稳定可采用阶梯式反应:从静脉输液开始,根据血流动力学损害类型(心动过缓、左心室功能障碍、血管扩张)启用单种或联合儿茶酚胺正性肌力药和血管加压药。
  • 作者认为高剂量胰岛素正葡萄糖治疗可作为辅助正性肌力药引入,对其它治疗无反应者考虑VA-ECMO。
  • 所有干预的偏倚风险均高,证据几乎全部来自极低至低质量研究。

适用人群与场景

  • β受体阻滞剂中毒患者,检索范围涵盖病例报告、病例系列、动物研究、观察性研究等。

处置流程与药物剂量

  • 作者认为对心血管不稳定可采用阶梯式反应:第一步静脉输液;第二步根据血流动力学损害类型(心动过缓、左心室功能障碍、血管扩张)启用单种或联合儿茶酚胺正性肌力药和血管加压药;第三步高剂量胰岛素正葡萄糖治疗可作为辅助正性肌力药引入;第四步对其它治疗无反应者考虑VA-ECMO。
  • 高剂量胰岛素正葡萄糖治疗:先弹丸注射然后持续输注,维持剂量范围为1至10单位/kg/h;低血糖和低钾血症为常见不良反应。
  • 阿托品:多次静脉弹丸注射阿托品与心率和血压改善相关(1篇病例报告)。
  • 胰高血糖素:在2个病例系列、9篇病例报告和5项动物研究中与心率增加带来的轻微血流动力学改善相关。

研究设计与关键结果

  • 所有干预的偏倚风险均高。
  • 胃肠去污:15篇病例报告描述给予活性炭,5篇详述使用洗胃;因同时使用多种干预,难以就这些干预对死亡率或生存的相对贡献得出明确结论。
  • 儿茶酚胺、正性肌力药和血管加压药:16篇病例报告、3个病例系列和2项动物研究报告使用儿茶酚胺治疗β受体阻滞剂毒性,这些药物最可能提供生存获益并改善血流动力学。
  • 高剂量胰岛素正葡萄糖治疗:在10个病例系列中与死亡率获益相关;2篇病例报告显示在符合胰岛素给药(弹丸注射后持续输注)的时间范围内血流动力学明显改善;维持剂量范围为1至10单位/kg/h;尚不清楚在人体中高剂量胰岛素正葡萄糖治疗是否比儿茶酚胺和其它正性肌力药更能改善血流动力学反应;低血糖和低钾血症为常见不良反应。
  • VA-ECMO:在一项观察性研究和4个病例系列中,VA-ECMO与严重心源性休克或心脏骤停患者生存改善相关。
  • 胰高血糖素:在2个病例系列、9篇病例报告和5项动物研究中与心率增加带来的轻微血流动力学改善相关。
  • 钙剂:在6篇病例报告中3篇与血流动力学改善相关,但同时也联用多种其它治疗;2项动物研究也有报告。

证据类型、等级与局限

  • 证据类型:系统评价,纳入病例报告、病例系列、动物研究和观察性研究。
  • 所有干预的偏倚风险均高;证据几乎全部来自极低至低质量研究,且存在偏倚。
  • 局限:多种治疗常同时给予,难以归因;尚不清楚在人体中高剂量胰岛素正葡萄糖治疗是否比儿茶酚胺和其它正性肌力药更能改善血流动力学反应;原文未报告其它局限性。

对床旁实践的改变

  • 作者认为对β受体阻滞剂中毒所致心血管不稳定可采用阶梯式反应:从静脉输液开始,根据血流动力学损害类型(心动过缓、左心室功能障碍、血管扩张)启用单种或联合儿茶酚胺正性肌力药和血管加压药;高剂量胰岛素正葡萄糖治疗可作为辅助正性肌力药引入;对其它治疗无反应者考虑VA-ECMO。
  • 高剂量胰岛素正葡萄糖治疗维持剂量范围为1至10单位/kg/h,需监测低血糖和低钾血症。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 2 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

Introduction: Beta-adrenoreceptor antagonist (beta-blocker) poisoning is a common overdose which can lead to significant morbidity and mortality.Objective: To evaluate the effects of treatments for beta-adrenoreceptor antagonist poisoning.Methods: Searches were conducted across MEDLINE (1946-26 November 2019, Ovid); Embase (1974-26 November 2019, Ovid); and the Cochrane Central Register of Controlled Trials (CENTRAL, to 26 November 2019) utilising a combination of subject headings and free text. The search strategy identified 15, 553 citations. Two reviewers screened titles and abstracts prior to selecting 141 articles (Kappa on articles included = 0.982, 95% CI 0.980-0.985). Primary outcomes included mortality and improvement in haemodynamic parameters (e.g., heart rate, blood pressure or a composite measure able to quantitate a haemodynamic response).Results: The risk of bias was high for all interventions.Gastric decontamination: Fifteen case reports described the administration of activated charcoal and five detailed the use of gastric lavage. As there was concurrent utilisation of multiple interventions, it was difficult to draw definitive conclusions regarding the relative contribution of these interventions to mortality or survival.Catecholamines, inotropes and vasopressors: The use of catecholamines in treating beta-blocker toxicity was reported in 16 case reports, 3 case series and 2 animal studies. These agents most likely provided a survival benefit and improved haemodynamics.Atropine: Multiple intravenous boluses of atropine were associated with improvement in heart rate and blood pressure in one case report.Calcium: Intravenous calcium was associated with an improvement in haemodynamics in three out of six case reports but in association with multiple other therapies as well as in two animal studies.High-dose insulin euglycaemic therapy: The use of this therapy was associated with mortality benefit in 10 case series. Two case reports showed clear haemodynamic improvement in a timeframe consistent with insulin administration (bolus then continuous infusion). Maintenance dosing ranged from 1 to 10 units/kg/h of insulin. However, it is unclear whether high-dose insulin euglycaemic therapy improved haemodynamic response above catecholamines and other inotropic agents in humans. Hypoglycaemia and hypokalemia were commonly observed adverse effects.Glucagon: Glucagon was associated with minor improvements in haemodynamics through an increase in heart rate in two cases series, nine case reports and five animal studies.Methylthioninium chloride (methylene blue): Four case reports reported an association with improvement in haemodynamics following administration of methylene blue but in the setting of co-ingestion with amlodipine.Intravenous lipid emulsion therapy: There was variable response to intravenous lipid emulsion therapy reported in 10 case series, 5 animal studies and 21 case reports.Lignocaine: There were four case reports showing variable response to lignocaine in arrhythmias secondary to beta-blocker toxicity.Other treatments: Fructose diphosphate, levosimendan and amrinone did not provide a mortality or significant haemodynamic benefit in three animal studies and nine case reports. .Veno-arterial extracorporeal membrane oxygenation: Veno-arterial extracorporeal membrane oxygenation was associated with improved survival in patients with severe cardiogenic shock or cardiac arrest in an observational study and four cases series.Dialysis: The evidence of four case reports suggest haemodialysis may assist in the management of massive overdose of specific water-soluble beta-blockers (e.g., atenolol) by improving elimination; however, a survival or haemodynamic benefit was not established.Pacing: One case series and a single case report showed the utility of temporary overdrive cardiac pacing to prevent arrhythmias in sotalol toxicity.Conclusions: Catecholamines, vasopressors, high-dose insulin euglycaemic therapy and veno-arterial extracorporeal membrane oxygenation were associated with reduced mortality. However, it must be acknowledged that multiple treatments were often given simultaneously. Haemodynamic improvements in blood pressure and cardiac output were seen with the use of catecholamines, vasopressin and high-dose insulin euglycaemic therapy. Evidence for treatment recommendations is almost entirely drawn from very low- to low-quality studies and subject to bias. However, it is reasonable to have a graduated response to cardiovascular instability beginning with intravenous fluids, commencement of a single or a combination of catecholamine inotropes and vasopressors depending upon the type of haemodynamic compromise (bradycardia, left ventricular dysfunction, vasodilation). High-dose insulin euglycaemic therapy can be introduced as an adjunctive inotrope and lastly, more invasive methods such as veno-arterial extracorporeal membrane oxygenation should be considered in cases unresponsive to other therapies.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Rotella JA, Greene SL, Koutsogiannis Z, et al. Treatment for beta-blocker poisoning: a systematic review. Clin Toxicol (Phila). 2020. PMID: 32310006. doi:10.1080/15563650.2020.1752918

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。